Overview

Dexmedetomidine for Sedation During Radiological Interventional Procedures

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Evaluation of the role of dexmedetomidine as a sole agent in sedating patients undergoing interventional radiological procedures and measuring its different outcome variables.
Phase:
Phase 4
Details
Lead Sponsor:
National Cancer Institute, Egypt
Treatments:
Dexmedetomidine